Effects of GLP-1 RAs on Human Lactation Outcomes
NCT07720414
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
There is increasing interest in using GLP-1 Receptor Agonist (GLP-1 RA) medications after pregnancy. This study is designed to determine if these medications affect breastmilk production or the nutritional makeup of breastmilk. The main questions the study will address are: Does GLP-1 RA-induced weight loss increase or decrease breastmilk production? Does GLP-1 RA-induced weight loss affect the nutritional composition of milk, including milk fat content?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Lactation
- Weight Loss
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- University of Colorado, Denver
- Last updated on ClinicalTrials.gov
- July 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- University of Colorado Anschutz School of Medicine · Aurora, CO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.